WillItSurvive
Medical technology and health companies · Portugal

Sword Health

swordhealth.com ↗

Sword Health runs AI-guided digital physical therapy and MSK care for large employers.

Defensible for now
Assessed 22 July 2026 · Evidence as of 22 July 2026
Real protection, with named pressure against it.
On the recordSince 22 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Kaia Health integration and Pulse cardiometabolic rollout progress
The call

Sword Health stands on cash flow, contracts, and clinical data, while its closest rival Hinge Health competes for the same enterprise buyers.

Sword Health helps employers and insurers treat muscle and bone injuries through apps, coaching, and AI, generating $240 million in annual revenue and making money today. The company faces real competition from Hinge Health, a larger public rival selling similar services to the same employers, though neither has yet knocked the other out of the market. The real question is whether Sword can keep its margins healthy as it adds new AI features and whether it can go public soon enough to give employees a way to cash out, since waiting until 2028 or later creates risk that people leave before that day comes.

Why
01
AI pressure: Consumer AI health assistants (e.g. OpenAI health tools, Google AI Health Coach). Free AI chat coaching could handle basic MSK advice, squeezing demand for paid structured programs. Could AI do the core job? Unlikely.
02
Bigger players: Hinge Health. Larger, public peer competes head to head for the same enterprise MSK contracts and renewals. Could a giant copy it? No, they are blocked.
03
What protects it. FDA-listed hardware, clinical outcomes data, and 1,000+ signed employer contracts create real switching costs.
What would change this call
Sword loses enterprise renewal RFPs to Hinge Health in 2026. Would show Hinge is actively taking share, not just co-existing.
Gross margins as Phoenix AI scales reported in future funding or press disclosures. Tests whether cash-flow-positive claim holds as AI care expands.
Kaia Health integration outcomes and member retention through mid-2026. Shows whether the acquisition adds strength or causes customer loss.
Key numbers
  • Revenue run rate ~$240M (2025-06-17)
  • Valued at $4B in Series F (2025-06-17)
  • Acquired Kaia Health for $285M (2026-01-28)
Named risks
  • IPO delayed to at least 2028 creates prolonged equity illiquidity for employees and investors. Severity: medium
  • Kaia Health integration (Jan 2026, $285M) carries execution risk and possible member attrition in Germany/US. Severity: medium
  • Larger public rivals Hinge Health and Omada Health have IPO capital and market visibility Sword lacks. Severity: medium
  • Unverified lawsuit by A2 Academy against founder Bento over 5% equity dispute, single-source and uncorroborated. Severity: low
  • Sector-wide tightening of FDA/CMS scrutiny on AI-driven digital therapeutics could slow certifications. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Hinge HealthcontestingPublic since 2025 IPO, larger co-leader in enterprise digital MSK market as of Jan 2025
Omada HealthcontestingIPO'd on Nasdaq as OMDA May 2025, overlapping in cardiometabolic and MSK care
Kaia Healthgaining onSword acquired this rival outright for $285M on Jan 28, 2026, removing it as a competitor
Questions people ask
Is Sword Health profitable?
Sword Health's CEO confirmed the company is cash-flow positive as of June 17, 2025, alongside a company-stated annual revenue run-rate of about $240M, per TechCrunch's report on its $40M Series F raise at a $4B valuation.
Who owns Sword Health?
Sword Health is privately held and venture-backed, with investors including General Catalyst, Khosla Ventures, Founders Fund, and Sapphire Ventures. Its Series F round (June 17, 2025) valued it at $4B; founders Virgilio Bento and Marcio Colunas started it in Porto in 2015.
Is Sword Health laying off employees?
In October 2024, Sword Health cut 17% of its workforce, specifically treatment-facing clinicians, explicitly tied to shifting clinical workflows onto its AI Care Specialist, Phoenix. Overall headcount later grew through 2025 amid product and M&A expansion.
Could AI replace Sword Health's physical therapists?
Sword Health is actively replacing 1:1 clinician time with its AI Care Specialist, Phoenix, launched June 4, 2024. This directly preceded a 17% October 2024 layoff of treatment-facing clinicians, showing AI substitution already reshaping the company's own workforce.
Who is Sword Health's biggest competitor?
Hinge Health, which went public in 2025, is Sword Health's closest and largest rival in enterprise digital musculoskeletal care. Omada Health, which IPO'd on Nasdaq as OMDA in May 2025, is a secondary competitor with chronic-care focus overlapping MSK.
When will Sword Health go public?
Sword Health's CEO told TechCrunch on June 17, 2025 that IPO plans have been pushed to 'at least 2028,' a notable delay compared to peers Hinge Health and Omada Health, which both completed IPOs in 2025.
Timeline
  • 2026-03-17Launched unified AI Care Platform spanning MSK, women's, mental, cardiometabolic care
  • 2026-03-11Launched Pulse, an AI cardiometabolic care product
  • 2026-01-28Acquired Kaia Health for $285M, entering Germany's DiGA market
  • 2026-01-01Announced US patent for reinforcement learning in clinical AI evolution
  • 2025-10-15Rolled out Thrive Pad hardware and camera-based Vision AI in mobile app
  • 2025-07-29Launched Sword Intelligence, a B2B AI-agent division for providers/payers
  • 2025-06-17Raised $40M Series F at $4B valuation, pushed IPO plans to at least 2028
  • 2025-06-17Launched Mind, a mental health care product
  • 2024-10-31Cut 17% of workforce, treatment-facing clinicians, tied to AI shift
  • 2024-06-04Launched Phoenix, its voice-based AI Care Specialist
Revision history
22 July 2026
First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.
In the same band
AbridgeSeegeneOlympus Corporation
More in Medical technology and health companies →
Sources